• OPEN AN ACCOUNT
Indian Indices
Sensex
77,264.51 330.92
( 0.43%)
Global Indices
Nasdaq
53,583.69 98.81
(0.18%)
Dow Jones
7,750.97 54.27
(0.71%)
Hang Seng
66,369.62 237.64
(0.36%)
Nikkei 225
10,795.58 -82.54
(-0.76%)
Forex
USD-INR
95.26 -0.05
(-0.05%)
EUR-INR
111.07 -0.11
(-0.10%)
GBP-INR
129.70 -0.28
(-0.21%)
JPY-INR
0.60 0.00
(0.01%)

EQUITY - MARKET SCREENER

Curis Lifesciences Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
94348
INE1BZN01016
58.5748291
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
CURIS
14.58
101.02
EPS(TTM)
Face Value()
Div & Yield %
8.57
10
0
 

Sarvamangal Mercantile Co. reports standalone net profit of Rs 0.11 crore in the June 2026 quarter
Aug 12,2026
Net profit of Sarvamangal Mercantile Co. reported to Rs 0.11 crore in the quarter ended June 2026 as against net loss of Rs 0.03 crore during the previous quarter ended June 2025. There were no Sales reported in the quarter ended June 2026 and during the previous quarter ended June 2025.